selatogrel
selatogrel: 4 clinical trials tracked.
selatogrel evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about selatogrel, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (4)
A Randomized, Open-label, 3-period Cross-over Study to Assess the Pharmacokinetics of Selatogrel (ACT-246475) in Healthy Subjects After Subcutaneous Administration by Syringe and Auto-injector
Primary endpoint: Area under the plasma concentration-time curve (AUC0-t) of selatogrel
An Open-label, Single-dose, Phase 1 Study to Evaluate the Pharmacokinetics of Selatogrel in Subjects With Mild and Moderate Hepatic Impairment Compared to Matched Healthy Subjects
Primary endpoint: The maximum plasma concentration (Cmax) of selatogrel
A Multi-center, Open-label, Randomized, Study to Assess the Onset of Platelet Aggregation Inhibition After a Single Subcutaneous Injection of ACT-246475 in Adults With Acute Myocardial Infarction
Primary endpoint: Number of Participants With a Pharmacodynamic Response as Assessed by the Inhibition of Platelet Aggregation
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Primary endpoint: Number of Participants With a Pharmacodynamic Response as Assessed by the Inhibition of Platelet Aggregation